CNS infections have severe manifestations, often leading to high mortality, but the CNS is usually not the primary target of pathogens, leaving a window of opportunity to prevent neuroinvasion. We must prioritize development of therapies to prevent neurological sequelae that cause long-lasting morbidity and disease burden on society.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Disentangling etiologies of CNS infections in Singapore using multiple correspondence analysis and random forest
Scientific Reports Open Access 26 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jones, K. E. et al. Global trends in emerging infectious diseases. Nature 451, 990–993 (2008).
Chang, L. Y. et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 356, 1226–1234 (2007).
Weaver, S. C. & Lecuit, M. Chikungunya virus infections. N. Eng. J. Med. 372, 1231–1239 (2015).
de Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203–1207 (2006).
Kleinschmidt-DeMasters, B. K. & Tyler, K. L. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Eng. J. Med. 353, 369–374 (2005).
Granerod, J. et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect. Dis. 10, 835–844 (2010).
Weisfelt, M., van de Beek, D., Spanjaard, L., Reitsma, J. B. & de Gans, J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 5, 123–129 (2006).
van de Beek, D. et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol. 9, 254–263 (2010).
Oliphant, T. et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11, 522–530 (2005).
Tauber, E. et al. Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 370, 1847–1853 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ng, L., Solomon, T. Major advances against a moving target of CNS infections. Nat Rev Neurol 11, 623–624 (2015). https://doi.org/10.1038/nrneurol.2015.202
Published:
Issue date:
DOI: https://doi.org/10.1038/nrneurol.2015.202
